StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Integra LifeSciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Integra LifeSciences's pe ratio was 64.7× on Oct 31, 2024, against 22.9× a year earlier. Over the last 5 years it ranged from 18.4× to 168.1×, with a median of 34.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 202464.7×+28.7
2023Dec 29, 202336.0×+8.8
2022Dec 30, 202227.2×+0.8
2021Dec 31, 202126.4×−70.5
2020Dec 31, 202096.9×+12.4
2019Dec 31, 201984.5×+38.9
2018Dec 31, 201845.6×−32.9
2017Dec 29, 201778.5×+24.2
2016Dec 30, 201654.3×+6.3
2015Oct 30, 201548.0×−3.0
2014Dec 31, 201451.1×−4.1
2013Oct 31, 201355.2×+24.6
2012Dec 31, 201230.6×+10.9
2011Dec 30, 201119.8×−0.7
2010Dec 31, 201020.5×−14.3
2009Dec 31, 200934.7×–

More Integra LifeSciences figures

See a number that looks wrong?